Serum levels of hepatitis C virus RNA predict non-response to interferon therapy: Comparison of two commercial assays

Journal of Viral Hepatitis

Volumn 6, Issue 1, 1999, Pages 65-71

  Soffredini, R ^a   Rumi, M G ^a   Del Ninno, E ^a   Parravicini, M L ^a   Russo, A ^b   Colombo, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

HCV RNA quantification; HCV viraemia; Predictive factor

Indexed keywords

ALPHAN1 INTERFERON; RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VIREMIA; VIRUS HEPATITIS;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VIREMIA;

EID: 0032988013     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.6120130.x     Document Type: Article

References (20)

1. Gordon SC, Kodali VP, Silverman AL et al. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis. Am J Gastroenterol 1994; 89: 1458-1461.
2. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohio M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993; 18: 16-20.
3. Rumi MG, Del Ninno E, Parravicini ML et al. A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C. Hepatology 1996; 24: 1366-1370.
4. Shiratory Y, Kato N, Yokosuka O et al. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Gastroenterology 1997; 113: 558-566.
5. Pawlotsky JM, Roudot-Thoraval F, Bastie A et al. Factors affecting treatment responses to interferon-α in chronic hepatitis C. J Infect Dis 1996; 174: 1-7.
6. Pawlotsky JM. Measuring hepatitis C viremia in clinical samples: can we trust the assays? Hepatology 1997; 26: 1-1.
7. Hawkins A, Davidson F, Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2 and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol 1997; 35: 187-192.
8. Gretch DR, dela Rosa C, Carithers RL, Willson RA, Williams B, Corey L. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Int Med 1995; 123: 321-329.
9. Young KKY, Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993; 31: 882-886.
10. Miskovsky EP, Carrella AV, Gutekunst K, Sun CA, Quinn TC, Thomas DL. Clinical characterization of a competitive PCR assay for quantitative testing of hepatitis C virus. J Clin Microbiol 1996; 34: 1975-1979.
11. Detmer J, Lagier R, Flynn J et al. Accurate quantification of HCV-RNA from all HCV genotypes using branched-DNA (bDNA) technology. J Clin Microbiol 1996; 34: 901-907.
12. Collins ML, Zayati C, Detmer JJ et al. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem 1995; 226: 120-129.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
14. Gretch D, Corey L, Wilson J et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis 1994; 169: 1219-1225.
15. Hagiwara H, Hayashi N, Kasahara A et al. Treatment with recombinant interferon-α2a for patients with chronic hepatitis C: predictive factors for biochemical and virological response. Scand J Gastroenterol 1996; 31: 1021-1026.
16. Hollingsworth RC, Sillekens P, van Deursen P, Neal KR, Irving WL on behalf of the Trent HCV Study Group. Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, lack of correlation with liver disease. J Hepatol 1996; 25: 301-306.
17. Nguyen TT, Sedghi-Vaziri, Wilkes LB et al. Fluctations in viral load (HCV-RNA) are relatively insignificant in untreated patients with chronic HCV infection. J Viral Hep 1996; 3: 75-78.
18. Zeuzem S, Franke A, Lee JH, Herrmann G, Ruster B, Roth WK. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology 1996; 24: 1003-1009.
19. Gretch DR, dela Rosa C, Corey L, Carithers RL. Assessment of hepatitis C viremia using molecular amplification technologies. Viral Hep Rev 1996; 2: 85-96.
20. Trabaud MA, Bailly F, Si-Ahmed SN et al. Comparison of HCV-RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon. J Med Virol 1997; 52: 105-112.